Enagas open to European regulated asset deals aligned with hydrogen-focused strategy, CEO says | ReutersSkip to main content[Exclusive news, data and analytics for financial market professionalsLearn more aboutRefinitiv]Enagas CEO Arturo Gonzalo speaks at Zona Franca near Barcelona, Spain February 2, 2023. REUTERS/Albert Gea/File Photo [Purchase Licensing Rights, opens new tab]- Companies[Enagas SA]FollowMADRID, Feb 17 (Reuters) - Spain's Enagas [(ENAG.MC), opens new tab] is open to acquiring regulated ener ...

Danaher will acquire pulse oximeter maker Masimo for $9.9 billion, the company said on Tuesday, as the contract research firm looks to bulk up its diagnostics portfolio. ...

Laboratory services provider Labcorp forecast annual profit above Wall Street estimates on Tuesday, banking on robust demand for its diagnostic tests. ...

Air India, Germany's Lufthansa tie up to grow passenger traffic | ReutersSkip to main content[Exclusive news, data and analytics for financial market professionalsLearn more aboutRefinitiv]A Lufthansa plane moves on the tarmac at Leonardo da Vinci International Airport in Fiumicino, near Rome, Italy, September 23, 2024. REUTERS/Remo Casilli [Purchase Licensing Rights, opens new tab]Feb 17 (Reuters) - Air India and Lufthansa [(LHAG.DE), opens new tab] plan to fly more passengers between India and Europe and ...

Core Insights - eToro exceeded profit estimates for Q4, driven by growth across various asset classes, with shares rising approximately 8.9% pre-market [1] - The company's assets under administration increased by 11% year-on-year to $18.5 billion, indicating strong performance in its multi-asset business model [1] - Despite the positive overall results, net contribution fell by 10% to $227 million, reflecting challenges in the crypto market [1] Financial Performance - eToro reported an adjusted profit of 71 cents per share for the three months ending December 31, surpassing analysts' average estimate of 63 cents per share [1] - The growth in U.S. equity markets during the quarter was supported by interest-rate cuts, although crypto market volatility raised caution among investors [1] Market Context - The emergence of new fintech firms is challenging traditional Wall Street institutions by attracting younger investors with lower trading costs and user-friendly platforms [1] - Concerns about a potential bubble in the market have arisen due to high valuations in select AI-linked stocks [1]

Core Viewpoint - Leidos Holdings reported fourth-quarter revenue below Wall Street estimates due to the impact of a six-week U.S. government shutdown, which disrupted operations and orders for defense contractors [1] Financial Performance - Leidos' fourth-quarter revenue was $4.21 billion, a decrease of 3.6% from the previous year and lower than analysts' expectations of $4.31 billion [1] - The company's adjusted profit per share for the fourth quarter was $2.76, exceeding expectations of $2.61, aided by a 160-basis point expansion in adjusted core profit margin and improved cost controls [1] Segment Performance - The health and civil segment, which provides electronic health record systems to the Department of Defense and Veteran Affairs hospitals, experienced a 9.3% drop in sales [1] Future Outlook - Leidos forecasted 2026 adjusted profit per share to be between $12.05 and $12.45, with the midpoint being 4 cents lower than analysts' estimates of $12.29 [1]

Activist investor Jana Partners builds stake in Fiserv, WSJ reports | ReutersSkip to main content[Exclusive news, data and analytics for financial market professionalsLearn more aboutRefinitiv]- Companies[Fiserv Inc]FollowFeb 17 (Reuters) - Activist investor Jana Partners has built a stake in Fiserv [(FISV.O), opens new tab] and is pressing the payments company to pursue steps to lift its lagging share price, the Wall Street journal reported on Tuesday.Shares of the company were up 6.5% in premarket trading ...

Ocular Therapeutix's eye drug superior to Regeneron's Eylea in late-stage trial | ReutersSkip to main content[Exclusive news, data and analytics for financial market professionalsLearn more aboutRefinitiv]- Companies[Ocular Therapeutix Inc]Follow[Regeneron Pharmaceuticals Inc]FollowFeb 17 (Reuters) - Ocular Therapeutix [(OCUL.O), opens new tab] said on Tuesday its experimental eye disease drug was more effective in helping patients maintain their vision compared to Regeneron's [(REGN.O), opens new tab] appr ...

Standards: [The Thomson Reuters Trust Principles., opens new tab][Purchase Licensing Rights][Milana Vinn]Thomson ReutersMilana Vinn reports on technology, media, and telecom (TMT) mergers and acquisitions. Her content usually appears in the markets and deals sections of the website. Milana previously worked at GLG and PE Hub, where she spent several years covering TMT deals in private equity. She graduated from CUNY Graduate School of Journalism with Masters in Business Journalism.## Read Nextago [Sustainab ...

UK lawsuit over smartphone chip royalties will be withdrawn][Retail & Consumercategory] [General Mills cuts annual sales and profit forecast][category] [FTSE 100 ticks up as soft jobs data raises rate cut bets; metal prices drag miners] Morning Bid: Sleepy 'uber-bulls' | ReutersSkip to main content[Exclusive news, data and analytics for financial market professionalsLearn more aboutRefinitiv]Traders work on the floor at the New York Stock Exchange (NYSE) in New York City, U.S., February 13, 2026. REUTERS/Br ...